Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 120,015,288
  • Shares Outstanding, K 258,053
  • Annual Sales, $ 9,869 M
  • Annual Income, $ 3,620 M
  • 60-Month Beta 0.40
  • Price/Sales 12.11
  • Price/Cash Flow 31.60
  • Price/Book 8.09
Trade VRTX with:

Options Overview Details

View History
  • Implied Volatility 28.41% ( +1.36%)
  • Historical Volatility 20.28%
  • IV Percentile 74%
  • IV Rank 64.45%
  • IV High 34.35% on 01/16/24
  • IV Low 17.64% on 05/16/24
  • Put/Call Vol Ratio 1.07
  • Today's Volume 775
  • Volume Avg (30-Day) 1,305
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 39,834
  • Open Int (30-Day) 41,818

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 3.60
  • Number of Estimates 11
  • High Estimate 4.42
  • Low Estimate 3.28
  • Prior Year 3.67
  • Growth Rate Est. (year over year) -1.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
456.07 +3.00%
on 09/24/24
493.00 -4.71%
on 09/03/24
-26.13 (-5.27%)
since 08/30/24
3-Month
456.07 +3.00%
on 09/24/24
510.64 -8.00%
on 08/01/24
-1.49 (-0.32%)
since 07/01/24
52-Week
341.85 +37.42%
on 10/03/23
510.64 -8.00%
on 08/01/24
+122.02 (+35.09%)
since 09/29/23

Most Recent Stories

More News
Vertex Announces Health Canada Acceptance of New Drug Submission for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis

/CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Health Canada has accepted for review its New Drug Submission (NDS) for...

VRTX : 469.76 (+1.01%)
Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

/CNW/ - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced Health Canada has granted Marketing Authorization for PrCASGEVY® (exagamglogene...

VRTX : 469.76 (+1.01%)
The Best Biotech Stock to Invest $1,000 in Right Now

Vertex Pharmaceuticals isn't an ordinary biotech stock.

VRTX : 469.76 (+1.01%)
Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Great companies have persisted even in a tumultuous market.

VRTX : 469.76 (+1.01%)
PINS : 32.76 (+1.20%)
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.

MRK : 114.74 (+1.04%)
PFE : 28.67 (-0.93%)
MRNA : 63.93 (-4.34%)
VRTX : 469.76 (+1.01%)
VKTX : 62.00 (-2.07%)
3 Stocks to Buy and Hold Forever

These stocks are built for the long run.

ABT : 113.56 (-0.39%)
ABBV : 196.96 (-0.26%)
LLY : 884.48 (-0.16%)
VRTX : 469.76 (+1.01%)
Prediction: These 3 Phenomenal Stocks Are Set to Soar

These stocks are already solid winners in 2024. They should be able to keep the momentum going.

DHI : 192.72 (+1.02%)
NVDA : 117.00 (-3.66%)
VRTX : 469.76 (+1.01%)
Is Vertex Pharmaceuticals Stock Outperforming the Nasdaq?

Vertex Pharmaceuticals has outperformed the Nasdaq over the past year, and analysts remain moderately bullish about the stock's prospects.

VRTX : 469.76 (+1.01%)
$NASX : 17,910.36 (-1.53%)
BMRN : 70.10 (-0.27%)
3 No-Brainer Stocks to Buy in September

There's at least one key common denominator here: tremendous growth prospects.

LLY : 884.48 (-0.16%)
NVO : 118.01 (-0.89%)
VRTX : 469.76 (+1.01%)
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever

These three have secure core businesses, plus multiple paths to grow.

ABT : 113.56 (-0.39%)
ABBV : 196.96 (-0.26%)
VRTX : 469.76 (+1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 485.21
2nd Resistance Point 478.76
1st Resistance Point 474.26
Last Price 469.76
1st Support Level 463.31
2nd Support Level 456.86
3rd Support Level 452.36

See More

52-Week High 510.64
Last Price 469.76
Fibonacci 61.8% 446.16
Fibonacci 50% 426.24
Fibonacci 38.2% 406.33
52-Week Low 341.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar